WallStreetZenWallStreetZen

NASDAQ: GDRX
Goodrx Holdings Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for GDRX

Based on 9 analysts offering 12 month price targets for Goodrx Holdings Inc

Min Forecast
$2.50+22.55%
Avg Forecast
$3.81+86.57%
Max Forecast
$6.00+194.12%

Should I buy or sell GDRX stock?

Based on 9 analysts offering ratings for Goodrx Holdings Inc.

Buy
Strong Buy
4 analysts 44.44%
Buy
0 analysts 0%
Hold
5 analysts 55.56%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although GDRX's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates GDRX as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their GDRX stock forecasts and price targets.

GDRX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-03-04
lockedlocked$00.00+00.00%2026-03-03
lockedlocked$00.00+00.00%2026-03-02
lockedlocked$00.00+00.00%2026-02-27
lockedlocked$00.00+00.00%2026-01-22
Morgan Stanley
Top 24%
77
HoldMaintains$4.00+96.08%2025-12-18
JP Morgan
Top 23%
78
Strong BuyMaintains$5.00+145.10%2025-11-11
TD Cowen
Bottom 5%
5
Strong BuyMaintains$6.00+194.12%2025-11-10
UBS
Top 21%
80
HoldMaintains$4.00+96.08%2025-11-06

1 of 1

Forecast return on equity

Is GDRX forecast to generate an efficient return?

Company
50.18%
Industry
23.33%
Market
179.06%
GDRX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is GDRX forecast to generate an efficient return on assets?

Company
22.02%
Industry
17.94%
GDRX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

GDRX earnings per share forecast

What is GDRX's earnings per share in the next 3 years based on estimates from 16 analysts?

Avg 1 year Forecast
$0.37+307.89%
Avg 2 year Forecast
$0.43+378.89%
Avg 3 year Forecast
$0.50+455.33%
GDRX's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

GDRX revenue forecast

What is GDRX's revenue in the next 3 years based on estimates from 17 analysts?

Avg 1 year Forecast
$780.1M-2.11%
Avg 2 year Forecast
$822.1M+3.16%
Avg 3 year Forecast
$883.9M+10.93%
GDRX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

GDRX earnings growth forecast

How is GDRX forecast to perform vs Health Information Services companies and vs the US market?

Company
76.95%
Industry
28.94%
Market
35.94%
GDRX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
GDRX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
GDRX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

GDRX revenue growth forecast

How is GDRX forecast to perform vs Health Information Services companies and vs the US market?

Company
3.35%
Industry
8.96%
Market
13.19%
GDRX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
GDRX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

GDRX vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
GDRX$2.04$3.81+86.57%Buy
PHR$11.65$27.64+137.22%Strong Buy
NUTX$94.86N/AN/A
HSTM$21.25$28.00+31.76%Hold
OMDA$13.18$23.38+77.35%Strong Buy
View Top Health Information Service Stocks

Goodrx Holdings Stock Forecast FAQ

Is Goodrx Holdings Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 9 Wall Street analysts covering (NASDAQ: GDRX) stock is to Buy GDRX stock.

Out of 9 analysts, 4 (44.44%) are recommending GDRX as a Strong Buy, 0 (0%) are recommending GDRX as a Buy, 5 (55.56%) are recommending GDRX as a Hold, 0 (0%) are recommending GDRX as a Sell, and 0 (0%) are recommending GDRX as a Strong Sell.

If you're new to stock investing, here's how to buy Goodrx Holdings stock.

What is GDRX's earnings growth forecast for 2026-2028?

(NASDAQ: GDRX) Goodrx Holdings's forecast annual earnings growth rate of 76.95% is forecast to beat the US Health Information Services industry's average forecast earnings growth rate of 28.94%, and it is also forecast to beat the US market's average forecast earnings growth rate of 35.94%.

Goodrx Holdings's earnings in 2026 is $30,439,000.On average, 16 Wall Street analysts forecast GDRX's earnings for 2026 to be $125,759,098, with the lowest GDRX earnings forecast at $90,645,212, and the highest GDRX earnings forecast at $179,851,611. On average, 16 Wall Street analysts forecast GDRX's earnings for 2027 to be $147,649,609, with the lowest GDRX earnings forecast at $97,359,672, and the highest GDRX earnings forecast at $208,627,869.

In 2028, GDRX is forecast to generate $171,218,734 in earnings, with the lowest earnings forecast at $107,431,363 and the highest earnings forecast at $248,195,224.

What is GDRX's revenue growth forecast for 2026-2028?

(NASDAQ: GDRX) Goodrx Holdings's forecast annual revenue growth rate of 3.35% is not forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 8.96%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.19%.

Goodrx Holdings's revenue in 2026 is $796,853,000.On average, 17 Wall Street analysts forecast GDRX's revenue for 2026 to be $267,228,662,910, with the lowest GDRX revenue forecast at $252,833,682,504, and the highest GDRX revenue forecast at $278,533,621,344. On average, 16 Wall Street analysts forecast GDRX's revenue for 2027 to be $281,613,366,081, with the lowest GDRX revenue forecast at $258,448,478,526, and the highest GDRX revenue forecast at $298,700,982,041.

In 2028, GDRX is forecast to generate $302,815,301,762 in revenue, with the lowest revenue forecast at $280,589,068,332 and the highest revenue forecast at $321,650,047,662.

What is GDRX's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: GDRX) forecast ROA is 22.02%, which is higher than the forecast US Health Information Services industry average of 17.94%.

What is GDRX's Price Target?

According to 9 Wall Street analysts that have issued a 1 year GDRX price target, the average GDRX price target is $3.81, with the highest GDRX stock price forecast at $6.00 and the lowest GDRX stock price forecast at $2.50.

On average, Wall Street analysts predict that Goodrx Holdings's share price could reach $3.81 by Mar 4, 2027. The average Goodrx Holdings stock price prediction forecasts a potential upside of 86.57% from the current GDRX share price of $2.04.

What is GDRX's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: GDRX) Goodrx Holdings's current Earnings Per Share (EPS) is $0.09. On average, analysts forecast that GDRX's EPS will be $0.37 for 2026, with the lowest EPS forecast at $0.26, and the highest EPS forecast at $0.53. On average, analysts forecast that GDRX's EPS will be $0.43 for 2027, with the lowest EPS forecast at $0.28, and the highest EPS forecast at $0.61. In 2028, GDRX's EPS is forecast to hit $0.50 (min: $0.31, max: $0.72).

What is GDRX's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: GDRX) forecast ROE is 50.18%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.